Maze Therapeutics, Inc.

MAZE · Healthcare · Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidne…

Maze Therapeutics, Inc. (MAZE), in the Healthcare sector, has 40 disclosed filings on Paydirt over the trailing twelve months from 5 corporate insiders: 0 purchases and 40 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Nov 2 and filed Nov 4. The most active filer was Harold Bernstein with 15 filings. Data as of Nov 8 2026.

Add to watchlist

Filings, ttm

0 buys · 40 sells

Traders, ttm

5 insiders

Volume, ttmiDollar value disclosed in the window

$22.5M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Nov 2

Filed Nov 4

ADViAverage daily dollar volume

$16.9M

market data

Share price · 12M

$34.19 (+12.1%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $22.9M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months

Harold Bernstein President, R&D & CMO 15 filings · 0 buys, 15 sales AD

Atul Dandekar CSBO 11 filings · 0 buys, 11 sales JC

Jason V Coloma Chief Executive Officer 8 filings · 0 buys, 8 sales AB

Amy Bachrodt SVP, Finance 5 filings · 0 buys, 5 sales RS

Richard H Scheller Director 1 filing · 0 buys, 1 sale CS

Catherine A. Sohn Director 1 filing · 0 buys, 1 sale

Recent filings

Jason V ColomaSALE Chief Executive Officer $965K
31,908 sh across 2 lots
Exec Nov 2
Filed Nov 4 · 4:13 PM ET Atul DandekarSALE CSBO $241K
7,500 sh × $32.07
Exec Oct 29
Filed Oct 30 · 4:14 PM ET Jason V ColomaSALE Chief Executive Officer $862K
31,908 sh × $27.02
Exec Oct 1
Filed Oct 2 · 4:12 PM ET Harold BernsteinSALE President, R&D & CMO $435K
16,141 sh × $26.93
Exec Oct 1
Filed Oct 2 · 4:09 PM ET Atul DandekarSALE CSBO $203K
7,500 sh × $27.06
Exec Sep 29
Filed Oct 1 · 4:06 PM ET Harold BernsteinSALE President, R&D & CMO $255K
9,705 sh × $26.22
Exec Sep 4
Filed Sep 8 · 4:20 PM ET Jason V ColomaSALE Chief Executive Officer $553K
21,134 sh across 2 lots
Exec Sep 2
Filed Sep 4 · 4:24 PM ET Harold BernsteinSALE President, R&D & CMO $252K
9,611 sh across 2 lots
Exec Sep 2
Filed Sep 4 · 4:22 PM ET Harold BernsteinSALE President, R&D & CMO $426K
16,141 sh × $26.36
Exec Sep 1
Filed Sep 3 · 4:24 PM ET Atul DandekarSALE CSBO $207K
7,500 sh × $27.58
Exec Aug 28
Filed Aug 31 · 6:32 PM ET Harold BernsteinSALE President, R&D & CMO $446K
16,142 sh × $27.61
Exec Aug 13
Filed Aug 14 · 4:54 PM ET Jason V ColomaSALE Chief Executive Officer $810K
30,304 sh × $26.71
Exec Aug 3
Filed Aug 5 · 4:08 PM ET Atul DandekarSALE CSBO $194K
7,100 sh × $27.31
Exec Jul 29
Filed Jul 31 · 4:15 PM ET Harold BernsteinSALE President, R&D & CMO $400K
13,409 sh × $29.86
Exec Jul 1
Filed Jul 2 · 4:29 PM ET Jason V ColomaSALE Chief Executive Officer $908K
30,311 sh × $29.95
Exec Jul 1
Filed Jul 2 · 4:28 PM ET Atul DandekarSALE CSBO $210K
7,500 sh × $28.02
Exec Jun 29
Filed Jul 1 · 4:17 PM ET Jason V ColomaSALE Chief Executive Officer $622K
23,865 sh × $26.05
Exec Jun 23
Filed Jun 24 · 5:30 PM ET Harold BernsteinSALE President, R&D & CMO $339K
13,253 sh × $25.57
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Jason V ColomaSALE Chief Executive Officer $160K
6,090 sh × $26.20
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Atul DandekarSALE CSBO $198K
7,500 sh × $26.34
Exec May 29
Filed Jun 2 · 5:30 PM ET Jason V ColomaSALE Chief Executive Officer $783K
30,086 sh across 2 lots
Exec May 22
Filed May 27 · 5:30 PM ET Harold BernsteinSALE President, R&D & CMO $393K
15,000 sh × $26.22
Exec May 14
Filed May 18 · 5:30 PM ET Atul DandekarSALE CSBO $190K
7,500 sh × $25.37
Exec Apr 29
Filed May 1 · 5:30 PM ET Harold BernsteinSALE President, R&D & CMO $433K
14,700 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET Atul DandekarSALE CSBO $196K
6,710 sh × $29.26
Exec Mar 30
Filed Apr 1 · 5:30 PM ET